Published in Ann Clin Res on February 01, 1978
Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med (1994) 4.76
Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med (1991) 4.09
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
Isolation of human NK cells by density gradient centrifugation. J Immunol Methods (1980) 3.30
Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res (1995) 2.31
Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer (1967) 1.99
Genital chlamydial infections in patients attending a gynaecological outpatient clinic. Br J Vener Dis (1978) 1.97
Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell Immunol (1979) 1.94
Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization. Cancer (1978) 1.84
Polarization of NK cell cytoskeleton upon conjugation with sensitive target cells. J Immunol (1983) 1.67
Ultrastructure of human natural killer cells: nature of the cytolytic contacts in relation to cellular secretion. J Immunol (1982) 1.65
Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets. Immunol Rev (1979) 1.58
Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells. Scand J Immunol (1979) 1.54
The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis (1996) 1.47
Sarcoidosis in identical twins. Observations on the course of treated and untreated identical diseases. Am Rev Respir Dis (1973) 1.44
The cytotoxic activity of human natural killer cells requires an intact secretory apparatus. Cell Immunol (1981) 1.40
Genital Chlamydia trachomatis infections in patients with cervical atypia. Obstet Gynecol (1979) 1.40
Elevated angiotensin I-converting enzyme in histiocytic medullary reticulosis. N Engl J Med (1983) 1.29
The sequence of chromosome aberrations during SV 40 transformation of a human diploid cell strain. Hereditas (1965) 1.29
The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis (1995) 1.27
c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J (1994) 1.24
Tumor-specific membrane antigens in established cell lines from gliomas. Cancer (1974) 1.22
Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study. Virchows Arch (2004) 1.19
Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease. Scand J Respir Dis (1979) 1.17
Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. Scand J Respir Dis (1978) 1.16
8-Trisomy in the bone marrow. Report of two cases. Clin Genet (1972) 1.16
Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology (1991) 1.15
Human natural cell-mediated cytotoxicity against fetal fibroblasts. III. Morphological and functional characterization of the effector cells. Cell Immunol (1979) 1.15
Chromosome pulverization in blood diseases. Hereditas (1981) 1.10
Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. Lab Invest (1988) 1.10
Are "natural killer" cells involved in allograft rejection? Eur J Immunol (1983) 1.08
[Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver]. J Natl Cancer Inst (1972) 1.08
The malignancy of mixed tumors of the parotid gland. A clinicopathological analysis of 70 cases. Acta Otolaryngol (1970) 1.07
Bacterial induction of human activated lymphocyte killing and its inhibition by lipopolysaccharide (LPS). J Immunol (1986) 1.07
Heat shock protects WEHI-164 target cells from the cytolysis by tumor necrosis factors alpha and beta. Eur J Immunol (1989) 1.06
Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction. Prog Med Virol (1984) 1.06
Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction. Eur Respir J (2001) 1.06
Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. EMBO J (1997) 1.05
Thrombocytosis in rheumatoid arthritis. Scand J Rheumatol (1972) 1.05
Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun (1993) 1.05
Thrombocytosis. Acta Med Scand (1973) 1.04
Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. Clin Exp Immunol (1973) 1.04
Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis (1990) 1.03
Ectopic pregnancy. Relationship to the preceding contraception. Ann Chir Gynaecol (1978) 1.03
Clinical and virological findings in patients with cytologically diagnosed gynecologic herpes simplex infections. Acta Cytol (1977) 1.03
Colposcopic and histologic findings in cervical chlamydial infection. Obstet Gynecol (1982) 1.02
Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. J Immunol (1986) 1.02
Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Eur Respir J (2002) 1.02
Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med (2003) 1.02
Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer? Br J Cancer (1995) 1.01
Chromosomal damage of human cells induced by Sendai virus. Ann Med Exp Biol Fenn (1965) 1.01
Decrease of the major high molecular weight surface glycoprotein of human granulocytes in monosomy-7 associated with defective chemotaxis. Blood (1979) 1.01
Non-specific binding of mouse immunoglobulins by swollen-bodied astrocytes--a potential source of confusion in human brain immunohistochemistry. Acta Neuropathol (1983) 1.00
Cytopathogenicity of cytomegalovirus to human ecto- and endocervical epithelial cells in vitro. Acta Cytol (1975) 1.00
Abnormalities of chromosome No. 17 in myeloproliferative disorders. Cancer Genet Cytogenet (1982) 0.99
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. Clin Cancer Res (2000) 0.99
Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos (1993) 0.98
Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists. Curr Pharm Des (2006) 0.98
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver. Scand J Gastroenterol (1973) 0.97
Studies of carcino-fetal proteins. II. Biochemical comparison of -fetoprotein from human fetuses and patients with hepatocellular cancer. Int J Cancer (1971) 0.97
Circulating immune complexes in sarcoidosis. J Clin Lab Immunol (1980) 0.96
Hemolytic anemia and thrombocytopenia in a case of left atrial myxoma associated with mitral stenosis. Am J Cardiol (1966) 0.96
Effect of a monoclonal anti-large granular lymphocyte antibody on the human NK activity. J Immunol (1982) 0.96
Function of neutrophils in preleukaemia. Scand J Haematol (1977) 0.95
True adherence with the Turbuhaler in young children with asthma. Arch Dis Child (2010) 0.95
Glycophorin A as a cell surface marker of early erythroid differentiation in acute leukemia. Int J Cancer (1979) 0.95
The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J (1999) 0.94
Cell-bound antiglial immunity in patients with malignant tumors of the brain. Cell Immunol (1973) 0.94
Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients. Eur Respir J (1998) 0.94
NK-9, a distinct sialylated antigen of the T200 family. Eur J Immunol (1986) 0.93
Human natural cell-mediated cytotoxicity against fetal fibroblasts. I. General characteristics of the cytotoxic activity. Cell Immunol (1977) 0.93
A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer. Br J Cancer (1998) 0.93
Transmission and spread of embryonic induction. II. Exclusion of an assimilatory transmission mechanism in kidney tubule induction. Exp Cell Res (1971) 0.93
Colposcopic and histological findings in cervical chlamydial infection. Lancet (1980) 0.93
Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic. Acta Psychiatr Scand (1977) 0.93
Parotid clear-cell adenoma of possible myoepithelial origin. Cancer (1972) 0.93
Sarcoidosis and myeloma of lambda-type IgG. Acta Med Scand (1974) 0.92
Serum lysozyme in sarcoidosis. Evaluation of its usefulness in determination of disease activity. Scand J Respir Dis (1977) 0.92
Sarcoidosis with thyroid involvement, polymyalgia rheumatica and breast carcinoma. A case report. Scand J Rheumatol (1976) 0.92
Functional MRI and motor behavioral changes obtained with constraint-induced movement therapy in chronic stroke. Eur J Neurol (2011) 0.91
The effect of neutropenia on myeloid growth and the stem cell in an in vivo culture system. Blood (1972) 0.91
Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study. Neurodegener Dis (2008) 0.91
Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. II. Functional investigations of the infiltrating inflammatory cells. Eur J Immunol (1978) 0.91
Prognostic significance of lymphopenia in sarcoidosis. Acta Med Scand (1979) 0.91
The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis (2000) 0.90
Specifically cytotoxic human and mouse lymphoid cells induced with antibody or antigen-antibody complexes. J Immunol (1975) 0.90
Heat shock inhibits the cytotoxic action of TNF-alpha in tumor cells but does not alter its noncytotoxic actions in endothelial and adrenal cells. Lymphokine Cytokine Res (1991) 0.90
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function. Eur Respir J (2008) 0.89
Kveim reaction in Crohn's disease. Lancet (1971) 0.88
Human natural cell-mediated cytotoxicity against fetal fibroblasts. II. Isolation and target cell specificity of the effector cells. Cell Immunol (1978) 0.88
Family studies in dermatitis herpetiformis. Ann Clin Res (1976) 0.88
Bone lesions in chronic myelogenous leukaemia. Acta Med Scand (1981) 0.88
Treatment of advanced esthesioneuroblastoma with high-dose chemotherapy and autologous bone marrow transplantation. A case report. Cancer (1985) 0.88
Effect of preoperative radiotherapy on the growth of human renal carcinoma tissue in vitro. Scand J Urol Nephrol (1973) 0.88
Atrophic enlargement of CSF volume after subarachnoid hemorrhage: correlation with neuropsychological outcome. AJNR Am J Neuroradiol (2009) 0.86
Two types of antibody dependent cell-mediated cytotoxicity, arming and sensitization. J Immunol (1976) 0.86
Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin. Report of three cases. Acta Med Scand (1975) 0.86